This page shows Zhen Ding (RBTK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The visible mechanic is liquidity strain: minimal cash and periodic financing support a business still carrying a fixed interest burden.
FY2025’s profit of$286.7K sits oddly beside interest expense of$497.9K , which means the year’s earnings did not come from a core operation that fully carries its financing burden. That reading is reinforced because operating cash flow was only$78.3K after a FY2024 net loss of-$1.1M , so the apparent turnaround looks more accounting-driven than cash-funded.
Short-term funding remains the binding constraint: FY2025 current assets were just
Book capital stayed underwater, with negative equity widening from
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Zhen Ding's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Zhen Ding's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
For every $1 of reported earnings, Zhen Ding generates $0.27 in operating cash flow ($78K OCF vs $287K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Zhen Ding earns $-0.2 in operating income for every $1 of interest expense (-$96K vs $498K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Zhen Ding reported $287K in net income in fiscal year 2025. This represents an increase of 125.9% from the prior year.
Zhen Ding earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Cash & Balance Sheet
Zhen Ding held $20K in cash against $0 in long-term debt as of fiscal year 2025.
Zhen Ding had 111M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
RBTK Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $13K | N/A | $41K+127.0% | $18K+4.0% | $17K | N/A | $45K+69.5% | $26K |
| Operating Income | -$13K | N/A | -$41K-127.0% | -$18K-4.0% | -$17K | N/A | -$45K-69.5% | -$26K |
| Interest Expense | $131K | N/A | $124K+1.4% | $123K-1.4% | $124K | N/A | $126K+2.0% | $124K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$144K | N/A | -$163K-15.3% | -$141K-119.3% | $733K | N/A | -$171K-13.9% | -$150K |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 |
RBTK Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Assets | $35K+74.0% | $20K-29.8% | $29K+41.9% | $20K-29.2% | $29K+1354.1% | $2K-70.1% | $7K-54.3% | $14K |
| Cash & Equivalents | $35K+74.0% | $20K-28.9% | $29K+55.6% | $18K-30.0% | $26K+1226.0% | $2K-70.1% | $7K-54.3% | $14K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | $11.4M+2.7% | $11.1M+2.9% | $10.8M+2.3% | $10.5M+2.5% | $10.3M-5.9% | $10.9M-2.4% | $11.2M+4.9% | $10.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.9M-2.7% | -$7.7M-3.2% | -$7.5M-2.4% | -$7.3M-2.9% | -$7.1M+6.2% | -$7.6M+2.3% | -$7.8M-5.3% | -$7.4M |
| Retained Earnings | -$23.4M-0.5% | -$23.3M-0.5% | -$23.2M-0.6% | -$23.0M-0.5% | -$22.9M+2.2% | -$23.4M-2.7% | -$22.8M-0.6% | -$22.7M |
RBTK Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$255K-12745.2% | $2K+104.7% | -$42K-88.8% | -$22K-115.9% | $141K+538.7% | -$32K-22.0% | -$26K+26.3% | -$36K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $34K+188.5% | $12K-73.1% | $43K+223.2% | $13K+113.7% | -$98K-851.9% | $13K-63.8% | $36K-13.8% | $42K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
RBTK Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$7.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Zhen Ding profitable?
Yes, Zhen Ding (RBTK) reported a net income of $287K in fiscal year 2025.
What is Zhen Ding's operating cash flow?
Zhen Ding (RBTK) generated $78K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What is Zhen Ding's current ratio?
Zhen Ding (RBTK) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Are Zhen Ding's earnings high quality?
Zhen Ding (RBTK) has an earnings quality ratio of 0.27x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Zhen Ding cover its interest payments?
Zhen Ding (RBTK) has an interest coverage ratio of -0.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Zhen Ding?
Zhen Ding (RBTK) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.